Search Results 2011-2020 of 24148 for Periods

1. A Study to Evaluate the Effectiveness and Safety of Aramchol Versus Placebo in Subjects With NASH (ARMOR) - Mayo Clinic

   ... period). Total NAS Score 4 or more with at least 1 in each component of the NAS Score (steatosis ≥ 1 AND inflammation ≥ 1 AND ballooning ≥ 1). Fibrosis ...

2. A Dose Ranging Study Evaluating Efficacy And Safety Of NI-03 - Mayo Clinic

   ... period; Patients on a non-opioid analgesic regimen that is expected to remain stable during the study period, or an opioid regimen with a morphine-equivalent ...

3. A Study of the Effect of Colesevelam on Glucose Metabolism in Patients with Type 2 Diabetes - Mayo Clinic

   Use of drugs or agents within the past 2 weeks or planned use in the subsequent 4 weeks during the study period that: Alter GI transit including laxatives ...

4. Safety, Tolerability And Pharmacokinetics Of AZD1613 In Adults With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

   ... period, or such interventions planned or anticipated within the follow-up period. Note: Other protocol defined Inclusion/Exclusion Criteria may apply ...

5. Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 (enrollment by invitation only) - Mayo Clinic

   Treatment with anti-IL 6, anti-IL-6R antagonists, or with Janus kinase inhibitors (JAKi) in the past 30 days or plans to receive during the study period ...

6. Pilonidal cyst - Symptoms and causes - Mayo Clinic

   Learn about causes, symptoms and treatments of this painful condition that usually affects the skin above the tailbone in people who sit for long periods.

7. Porphyria - Symptoms and causes - Mayo Clinic

   Hormone changes during the menstrual period. Complications. Possible complications depend on the form of porphyria: Acute porphyrias can be life-threatening if ...

8. A Study of Subcutaneous Nivolumab + Relatlimab FDC in Previously Untreated Metastatic or Unresectable Melanoma - Mayo Clinic

   ... Period with the sample collected within 3 months prior to randomization. All ... period for biomarker testing. Assessment of tumor-cell PD-L1 ...

9. Wearable Devices to Predict and Track Chronic Migraine Clinical Outcomes

   Also, to accurately forecast periods of increased headache likelihood to allow patients earlier and more effective treatments. Participation eligibility.

10. Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

    ... period and for at least 28 days after the last dose of study treatment to avoid exposing the embryo. Men must refrain from donating sperm during this same ...